What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
Aimin Xu focuses on Internal medicine, Endocrinology, Adiponectin, Insulin resistance and Adipokine.
Internal medicine is closely attributed to Diabetes mellitus in his work.
His Endocrinology study is mostly concerned with Steatosis, Glucose homeostasis, Endothelial dysfunction, Obesity and Type 2 diabetes.
His research investigates the connection between Steatosis and topics such as Fatty liver that intersect with issues in Fatty acid synthase, Fatty acid synthesis and Adiponectin receptor 2.
His Adiponectin study combines topics in areas such as Secretion, Biochemistry, Growth factor and Cell culture.
Insulin resistance is a subfield of Insulin that Aimin Xu studies.
His most cited work include:
- The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice (1070 citations)
- The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice (1070 citations)
- Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans (613 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Adiponectin, Insulin resistance and Diabetes mellitus.
As part of his studies on Internal medicine, Aimin Xu often connects relevant areas like Type 2 diabetes.
His research brings together the fields of Inflammation and Endocrinology.
His work in Adiponectin tackles topics such as Biochemistry which are related to areas like Cell biology.
His studies in Insulin receptor and Glucose homeostasis are all subfields of Insulin resistance research.
His study in Diabetes mellitus is interdisciplinary in nature, drawing from both Prospective cohort study and Risk factor.
He most often published in these fields:
- Internal medicine (68.24%)
- Endocrinology (62.79%)
- Adiponectin (29.22%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (68.24%)
- Endocrinology (62.79%)
- Diabetes mellitus (19.78%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Endocrinology, Diabetes mellitus, Adipose tissue and Insulin resistance are his primary areas of study.
His work deals with themes such as Gastroenterology and Type 2 diabetes, which intersect with Internal medicine.
His research in Endocrinology is mostly focused on Thermogenesis.
His Diabetes mellitus research includes elements of Body mass index, Biomarker, Obesity and Proportional hazards model.
Aimin Xu has researched Adipose tissue in several fields, including Senescence, Kidney and Hyperinsulinemia.
His study focuses on the intersection of Insulin resistance and fields such as M2 Macrophage with connections in the field of Systemic inflammation.
Between 2017 and 2021, his most popular works were:
- Adipocyte-secreted exosomal microRNA-34a inhibits M2 macrophage polarization to promote obesity-induced adipose inflammation (75 citations)
- Adipocyte-secreted exosomal microRNA-34a inhibits M2 macrophage polarization to promote obesity-induced adipose inflammation (75 citations)
- Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat. (60 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
His primary areas of investigation include Internal medicine, Endocrinology, Insulin resistance, Adipose tissue and Inflammation.
As a part of the same scientific family, Aimin Xu mostly works in the field of Internal medicine, focusing on Phosphorylation and, on occasion, Signal transduction.
His biological study spans a wide range of topics, including Neurogenesis and Transplantation.
His research in Insulin resistance intersects with topics in FGF21, Lutein, Carotenoid and M2 Macrophage.
His Inflammation research focuses on Adipokine and how it connects with Adipogenesis, Energy homeostasis, Ageing and Hyperinsulinemia.
His Adiponectin research is multidisciplinary, incorporating perspectives in Knockout mouse and Fibroblast growth factor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
